The pathways DNA repair, Myc targets, Reactive Oxygen Species pathway, and Kras Signaling pathway, which are typically linked to tumor development and tumor immune inflammation, were significantly enriched in patients in cluster B compared with patients in cluster A. Therefore, the reason that cluster B patients have a poor prognosis may be due to the activation of the aforementioned pathways. This evidence concerns the gene KRAS and neoplasm.